This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07788/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07788/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07788/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07788/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07788
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07788 n7:DB07788
dcterms:title
(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE
adms:identifier
n9:46937092 n10:99444259 n11:DB07788 n12:FRR
n3:IUPAC-Name
n4:271B3F3D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3F43-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3F42-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3F3F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3F40-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3F41-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3F3B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3F39-363D-11E5-9242-09173F13E4C5 n4:271B3F3C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3F3A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3F49-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3F4A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3F44-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3F45-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3F47-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3F46-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3F48-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3F4F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3F51-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3F52-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3F4E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3F4D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3F50-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3F3E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3F4B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3F4C-363D-11E5-9242-09173F13E4C5